###begin article-title 0
###xml 96 111 <span type="species:ncbi:10090">transgenic mice</span>
The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice
###end article-title 0
###begin p 1
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 549 552 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 545 552 545 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 1020 1023 1020 1023 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1016 1023 1016 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 1104 1108 1104 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1214 1218 1214 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 767 782 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
The role of the angiopoietin-1 (Ang1)-Tie2 pathway in the pathogenesis of pulmonary arterial hypertension (PAH) is controversial. Although Ang1 is well known to prevent endothelial activation and injury in systemic vascular beds, this pathway has been suggested to mediate pulmonary vascular remodeling in PAH. Therefore, we used transgenic models to determine the effect of increased or decreased Tie2 activity on the development of PAH. We now report modest spontaneous elevation in right ventricular systolic pressure in Tie2-deficient mice (Tie2+/-) compared with wild-type (WT) littermate controls, which was exacerbated upon chronic exposure to the clinically relevant PAH triggers, serotonin (5-HT) or interleukin-6 (IL-6). Moreover, overexpression of Ang1 in transgenic mice had no deleterious effect on pulmonary hemodynamics and, if anything, blunted the response to 5-HT. Exposure to 5-HT or IL-6 also decreased lung Ang1 expression, further reducing Tie2 activity and inducing pulmonary apoptosis in the Tie2+/- group only. Similarly, cultured pulmonary artery endothelial cells subjected to Tie2 silencing demonstrated increased susceptibility to apoptosis after 5-HT treatment. Finally, treatment of Tie2-deficient mice with Z-VAD, a pan-caspase inhibitor, prevented the pulmonary hypertensive response to 5-HT. Thus, these findings firmly establish that endothelial survival signaling via the Ang1-Tie2 pathway is protective in PAH.
###end p 1
###begin p 2
###xml 242 264 242 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Budhiraja et al., 2004</xref>
###xml 266 288 266 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib61">Voelkel and Cool, 2004</xref>
###xml 290 307 290 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Song et al., 2008</xref>
###xml 490 508 490 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">Tuder et al., 2001</xref>
The pathogenesis of pulmonary arterial hypertension (PAH) is complex and poorly understood; however, pulmonary arterial endothelial cell (EC) injury is considered to be a critical early mechanism in the initiation and progression of disease (Budhiraja et al., 2004; Voelkel and Cool, 2004; Song et al., 2008). The distal pulmonary arteriolar bed normally lacks muscularization at the level of the intraacinar arteriole, which essentially consists of an EC tube with limited matrix support (Tuder et al., 2001) exposed directly to the environment through inspired air. Therefore, we have hypothesized that these uniquely fragile precapillary structures may be particularly susceptible to damage upon exposure to environmental stress, especially in the context of genetic predisposition, and that EC apoptosis contributes to the functional and structural abnormalities of the pulmonary microvasculature characteristic of this disease.
###end p 2
###begin p 3
###xml 142 161 142 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Dumont et al., 1994</xref>
###xml 163 180 163 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">Sato et al., 1995</xref>
###xml 182 199 182 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">Suri et al., 1996</xref>
###xml 201 222 201 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">Ward and Dumont, 2002</xref>
###xml 474 502 474 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">Papapetropoulos et al., 2000</xref>
###xml 581 606 581 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Maisonpierre et al., 1997</xref>
###xml 753 769 753 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Kim et al., 2000</xref>
###xml 803 836 803 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">Teichert-Kuliszewska et al., 2001</xref>
Tie2 belongs to the family of endothelial-selective receptor tyrosine kinases and is essential for both embryonic and postnatal angiogenesis (Dumont et al., 1994; Sato et al., 1995; Suri et al., 1996; Ward and Dumont, 2002). Angiopoietin-1 (Ang1) and Ang2 are the principle Tie2 ligands. Ang1 is a Tie2 agonist and functions as a homeostatic factor in the postnatal vasculature, protecting against EC inflammation and apoptosis mainly through activation of the Akt pathway (Papapetropoulos et al., 2000). In contrast, Ang2 was first identified as an endogenous antagonist to Tie2 (Maisonpierre et al., 1997) but is now recognized to have context-dependent agonistic properties, and has been reported to activate the Tie2 receptor at high concentration (Kim et al., 2000) or during prolonged incubation (Teichert-Kuliszewska et al., 2001).
###end p 3
###begin p 4
###xml 114 137 114 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Chen and Stinnett, 2008</xref>
###xml 139 155 139 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Lai et al., 2008</xref>
###xml 157 173 157 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">Lee et al., 2008</xref>
###xml 480 507 480 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Thistlethwaite et al., 2001</xref>
###xml 509 524 509 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Du et al., 2003</xref>
###xml 641 664 641 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Kugathasan et al., 2005</xref>
###xml 666 687 666 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Eddahibi et al., 2006</xref>
###xml 807 824 807 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Wong et al., 1997</xref>
###xml 826 852 826 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">Witzenbichler et al., 1998</xref>
###xml 981 1002 981 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Sullivan et al., 2003</xref>
###xml 1039 1055 1039 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib78">Chu et al., 2004</xref>
###xml 1164 1168 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 1285 1302 1285 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib68">Zhao et al., 2003</xref>
###xml 1325 1348 1325 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Kugathasan et al., 2005</xref>
###xml 1699 1720 1699 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Sullivan et al., 2003</xref>
###xml 1722 1738 1722 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib78">Chu et al., 2004</xref>
###xml 395 403 <span type="species:ncbi:9606">patients</span>
###xml 629 634 <span type="species:ncbi:9606">human</span>
###xml 1073 1077 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Despite considerable evidence supporting a protective action for the Ang1-Tie2 pathway in systemic blood vessels (Chen and Stinnett, 2008; Lai et al., 2008; Lee et al., 2008), the role of this system in the pulmonary microvasculature, particularly in PAH, remains highly controversial. Thistlethwaite et al. reported remarkable increases in Ang1 expression and Tie2 activity in the lungs of PAH patients compared with control lung samples, in which both were nearly undetectable (Thistlethwaite et al., 2001; Du et al., 2003). However, other groups have found high basal levels of Ang1 expression and Tie2 activity in the normal human lung (Kugathasan et al., 2005; Eddahibi et al., 2006); indeed, the lung has been reported to exhibit the highest levels of Ang1-Tie2 expression and activity of all organs (Wong et al., 1997; Witzenbichler et al., 1998). Nonetheless, the Thistlethwaite group has also reported that overexpression of Ang1 by means of transfection with adenoviral (Sullivan et al., 2003) or adeno-associated viral vectors (Chu et al., 2004) produced PAH in rats. Again, these findings are in conflict with other reports demonstrating that nonviral Ang1 gene transfer reduced right ventricular systolic pressure (RVSP) and vascular remodeling in both the monocrotaline (Zhao et al., 2003) and chronic hypoxia (Kugathasan et al., 2005) models of PAH, even improving survival in the former. These discrepancies may be related to confounding influences of viral vectors that were used for transfection, because these may have proinflammatory effects, or surgical manipulation, in particular the clamping of delicate pulmonary veins that was performed to enhance pulmonary gene transfer (Sullivan et al., 2003; Chu et al., 2004).
###end p 4
###begin p 5
###xml 207 211 207 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 649 652 649 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
Therefore, in the present study we relied on transgenic approaches to study the effects of both loss or gain of function of the Ang1-Tie2 pathway on pulmonary hemodynamics and remodeling. We now report that Tie2 heterozygous deficient mice showed mild spontaneous increases in RVSP and an exaggerated pulmonary hypertensive response to chronic exposure to serotonin (5-HT) or IL-6. This was associated with decreased lung Ang1 levels and Tie2 receptor activation, and increased peripheral lung apoptosis in Tie2-deficient mice only. Moreover, the inhibition of apoptosis with a pan-caspase inhibitor, Z-VAD, prevented PAH in response to 5-HT in Tie2+/- animals, whereas overexpression of Ang1 using a conditional transgenic model did not result in PAH and, if anything, blunted the pulmonary hypertensive response to 5-HT exposure. Therefore, the evidence from these transgenic models supports the view that the Ang1-Tie2 pathway acts to protect against the development of PAH, largely by preventing apoptosis and early lung microvascular loss.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin title 7
###xml 42 45 42 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Phenotypic characterization of WT and Tie2+/- mice
###end title 7
###begin p 8
###xml 143 147 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 147 150 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 207 222 195 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, A and B</xref>
###xml 308 312 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 312 315 300 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 489 497 477 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 593 597 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 597 600 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 634 638 622 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 638 641 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 745 746 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 780 788 766 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 873 881 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 992 996 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 996 999 982 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1071 1079 1057 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 1229 1233 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1233 1236 1219 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1293 1294 1279 1280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1528 1532 1514 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1532 1535 1518 1521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 168 172 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 601 605 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 774 778 <span type="species:ncbi:10090">mice</span>
###xml 1017 1021 <span type="species:ncbi:10090">mice</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
###xml 1237 1241 <span type="species:ncbi:10090">mice</span>
###xml 1536 1540 <span type="species:ncbi:10090">mice</span>
Western blot analysis of lung Tie2 and endothelial NO synthase (eNOS) protein revealed a reduction of approximately50% in expression levels in Tie2+/- compared with WT mice (P < 0.01 and 0.05, respectively; Fig. 1, A and B). Interestingly, basal protein levels of Ang1 in the lung were slightly increased in Tie2+/- compared with WT mice (P < 0.01), whereas Ang2 levels were reduced (P < 0.01), resulting in a more than twofold increase in the ratio of lung Ang1 to Ang2 levels (P < 0.05; Fig. 1 C). Under basal conditions, there was a modest but significant difference in RVSP between WT and Tie2+/- mice (P < 0.05), with 13% of the Tie2+/- mice demonstrating a RVSP measurement >37 mmHg (two standard deviations above mean RVSP of WT mice; chi2, P < 0.05 compared with WT mice; Fig. 2 A); however, no significant change in baseline systemic systolic blood pressure (SBP; Fig. 2 B) or heart rate (unpublished data) was observed. A marked reduction in microvascular perfusion in the lungs of Tie2+/- compared with WT mice was revealed after fluorescent microangiography (Fig. 2 C). Furthermore, this perfusion abnormality was more pronounced in mice with higher RVSPs. To further characterize their susceptibility to PAH, WT and Tie2+/- mice were subjected to 1 wk of hypoxic exposure (8-10% O2). Chronic hypoxia resulted in a significant increase in RVSP and right ventricle (RV) hypertrophy (P < 0.05 and 0.01, respectively, compared with normoxic controls), but there was no significant difference between the hypoxic WT and Tie2+/- mice observed ().
###end p 8
###begin p 9
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Characterization of lung protein expression in WT and <italic>Tie2<sup>+/&#8722;</sup></italic> mice under basal conditions.</bold>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 204 207 204 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 200 207 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 354 361 354 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
Characterization of lung protein expression in WT and Tie2+/- mice under basal conditions. (A and B) Decreased lung Tie2 (A; n = 5 mice per group) and eNOS protein levels (B; n = 3 mice per group) in Tie2+/- compared with WT mice. (C) Increased lung Ang1 and decreased lung Ang2 protein levels, and increased ratio of lung Ang1 to Ang2 protein levels in Tie2+/- compared with WT mice (n = 5 mice per group). Results in A and C are from two independent experiments, and results in B are from one experiment. Data are presented as means +/- SEM. *, P < 0.05; **, P < 0.01 versus WT.
###end p 9
###begin p 10
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hemodynamic analysis and pulmonary fluorescent microangiography in WT and <italic>Tie2<sup>+/&#8722;</sup></italic> mice under basal conditions.</bold>
###xml 162 165 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 268 275 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 445 448 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 441 448 441 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 539 540 539 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 656 659 656 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 652 659 652 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
Hemodynamic analysis and pulmonary fluorescent microangiography in WT and Tie2+/- mice under basal conditions. (A) Elevation in baseline RVSP measurements in Tie2+/- (n = 55) compared with WT (n = 60) mice. (B) No significant difference in systemic SBP between WT and Tie2+/- mice was observed (n = 5 mice per group). (C) Fluorescent microangiography (whole top right lung lobe) illustrating decreased microcirculatory perfusion in baseline Tie2+/- compared with WT mice; perfusion is further reduced in mice with higher RVSP measurement (n = 5 mice per group). Results in A are from 10 independent experiments, each with similar proportions of WT and Tie2+/- mice; results in B are from 2 independent experiments; and representative photomicrographs in C are from three independent experiments. Data are presented as means +/- SEM. *, P < 0.05 versus WT. Bars, 0.25 cm.
###end p 10
###begin title 11
Effect of 5-HT or IL-6 on RVSP and RV hypertrophy
###end title 11
###begin p 12
###xml 76 84 76 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 106 114 106 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 790 794 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 794 797 788 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 944 948 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 948 951 938 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1075 1079 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1079 1082 1069 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1202 1206 1192 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1206 1209 1196 1199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
###xml 1227 1231 <span type="species:ncbi:10090">mice</span>
To determine the effect of well-known pulmonary hypertensive stimuli, RVSP (Fig. 3 A) and RV hypertrophy (Fig. 3 B) were assessed in WT and Tie2+/- mice after 1 wk of 5-HT infusion and 1 or 2 wk of IL-6 delivery. Treatment with 5-HT had no significant effect on RVSP in WT mice, although there was a trend (P < 0.1) toward an increase. However, 5-HT-treated Tie2-deficient mice exhibited a substantial increase in RVSP compared with their respective saline-treated controls (40 +/- 4 vs. 25 +/- 1 mmHg; P < 0.01). This increase was also significantly greater than that seen in WT mice exposed to 5-HT (27 +/- 2 mmHg; P < 0.05). Although no significant effect on RVSP was observed in any group after 1 wk of IL-6 delivery, 2 wk of exposure to IL-6 induced a significant elevation in RVSP in Tie2+/- mice compared with IL-6-treated WT mice (31 +/- 3 vs. 22 +/- 1 mmHg; P < 0.05). A trend (P < 0.1) toward an increase in RVSP was also observed in Tie2+/- mice compared with their saline-treated controls. No significant change in RV hypertrophy was observed in either the WT or Tie2+/- mice during the short period of treatment with 5-HT. However, a significant increase in RV hypertrophy was observed in Tie2+/- compared with WT mice after 2 wk of exposure to IL-6 (P < 0.05).
###end p 12
###begin p 13
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of 5-HT or IL-6 on RVSP and RV hypertrophy.</bold>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 175 182 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 234 241 234 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 469 472 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 465 472 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 549 550 549 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 608 611 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 604 611 604 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
Effect of 5-HT or IL-6 on RVSP and RV hypertrophy. (A) Increased RVSP in Tie2+/- mice exposed to 5 nmol/h 5-HT for 1 wk compared with WT mice and compared with saline-treated Tie2+/- mice (n = 12-15 mice per group). Increased RVSP in Tie2+/- mice exposed to 200 ng/kg/d IL-6 for 2 wk compared with WT mice (n = 9-13 mice per group). (B) No change in RV hypertrophy, assessed by evaluating the mass ratio of the RV to the left ventricle plus septum (LV+S), in WT or Tie2+/- mice exposed to 5 nmol/h 5-HT for 1 wk compared with saline-treated groups (n = 12-15 mice per group). Increased RV hypertrophy in Tie2+/- mice exposed to IL-6 for 2 wk compared with WT mice (n = 9-13 mice per group). Results are from three independent experiments. Data are presented as means +/- SEM. *, P < 0.05; **, P < 0.01 as indicated.
###end p 13
###begin title 14
Effect of 5-HT or IL-6 on Ang1 level and Tie2 activity
###end title 14
###begin p 15
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 162 177 162 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, A and B</xref>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 289 292 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 514 516 514 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 519 521 519 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 649 667 649 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">Modur et al., 1997</xref>
###xml 669 687 669 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Ammit et al., 2007</xref>
###xml 1024 1039 1012 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4, C and D</xref>
###xml 1202 1217 1190 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, A and B</xref>
###xml 1331 1335 1319 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1335 1338 1323 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1513 1529 1501 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 (A and B)</xref>
###xml 1611 1615 1599 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1615 1618 1603 1606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1625 1633 1613 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1682 1686 1670 1674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1686 1689 1674 1677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1883 1887 1871 1875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
###xml 1339 1343 <span type="species:ncbi:10090">mice</span>
###xml 1619 1623 <span type="species:ncbi:10090">mice</span>
###xml 1690 1694 <span type="species:ncbi:10090">mice</span>
Western blot analysis was performed on lung homogenates from WT and Tie2+/- mice to determine whether treatment with 5-HT or IL-6 altered endogenous Ang1 levels (Fig. 4, A and B). After 1 wk of exposure to 5-HT or IL-6, Ang1 levels were significantly and similarly decreased in WT and Tie2+/- mice compared with their respective saline-treated control groups (P < 0.05). To further establish the association between 5-HT and Ang1, human pulmonary artery smooth muscle cells (SMCs) were exposed for 24 h to 5-HT (10-8-10-5 M) or a combination of equal concentrations of IL-6 and a soluble IL-6R (sIL-6R; 10, 50, and 100 ng/ml), because past studies (Modur et al., 1997; Ammit et al., 2007) have demonstrated that the membrane-bound receptor may not be expressed in SMCs under in vitro conditions and that the soluble receptor is required to allow for IL-6 trans-signaling (). Ang1 secretion, as determined by ELISA performed on conditioned media, was reduced to approximately60% in response to 5-HT or IL-6/sIL-6R (P < 0.01; Fig. 4, C and D). To investigate the implications of these observations on in vivo Tie2 activity, Western blot analysis of phosphorylated Tie2 was performed on lung homogenates (Fig. 5, A and B). Although in WT mice no change in Tie2 receptor activation was observed after 5-HT infusion or IL-6 injections, Tie2+/- mice displayed a significant decrease in lung Tie2 receptor activation compared with their saline-treated groups, in parallel to the decreases in Ang1 levels demonstrated in Fig. 4 (A and B) (P < 0.05). Because baseline levels of eNOS were significantly down-regulated in Tie2+/- mice (Fig. 1 B), we examined eNOS protein expression in WT and Tie2+/- mice after 5-HT infusion (). Interestingly, although there was no significant reduction in lung eNOS protein levels after 5-HT exposure, a trend toward a decrease (P < 0.1) was observed in the Tie2-deficient group.
###end p 15
###begin p 16
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of 5-HT or IL-6 on Ang1 protein levels in vivo and in vitro.</bold>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 117 124 117 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 156 158 156 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> n</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 355 357 355 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 360 362 360 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 478 479 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
Effect of 5-HT or IL-6 on Ang1 protein levels in vivo and in vitro. (A) Decreased lung Ang1 protein levels in WT and Tie2+/- mice after exposure to 5-HT (A; n = 5 mice per group) or IL-6 (B; n = 5 mice per group) for 1 wk. (C and D) Decreased Ang1 protein secretion measured by ELISA in pulmonary artery SMCs serum starved overnight and stimulated with 10-8-10-5 M 5-HT (C; n = 4 per group) or equal concentrations of a combination of IL-6 and sIL-6R (10, 50, and 100 ng/ml; D; n = 4 per group) for 24 h. Results in A and B are from two independent experiments; results in C and D are from four independent experiments. Data are presented as means +/- SEM. *, P < 0.05; **, P < 0.01 versus saline (in vivo) or control (in vitro).
###end p 16
###begin p 17
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of 5-HT or IL-6 on lung Tie2 activity.</bold>
###xml 162 165 162 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 158 165 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 192 194 192 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> n</italic>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 291 294 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 287 294 287 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 490 493 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 486 493 484 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
Effect of 5-HT or IL-6 on lung Tie2 activity. (A and B) Decreased activation of Tie2, assessed by normalizing levels of phosphorylated Tie2 to total Tie2, in Tie2+/- mice treated with 5-HT (A; n = 4 mice per group) or IL-6 (B; n = 4 mice per group) for 1 wk compared with saline-treated Tie2+/- mice. No change in Tie2 activation was observed in WT mice. Results in A and B are from two independent experiments. Data are presented as means +/- SEM. *, P < 0.05 versus respective saline Tie2+/- mice.
###end p 17
###begin title 18
Cell-death analysis
###end title 18
###begin p 19
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 328 336 328 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 500 504 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 504 507 504 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 620 624 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 763 771 763 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
No terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining or propidium iodide (PI) uptake was detected in saline-treated WT or Tie2+/- mice (not depicted). In contrast, substantial TUNEL positivity was seen after 1 wk of exposure to 5-HT in Tie2-deficient but not in WT mice (7 vs. 0%; P < 0.01; Fig. 6 A). This increase in apoptosis was confirmed by in vivo perfusion of the pulmonary circulation with PI, which only stains the nuclei of nonviable cells. Again, only Tie2+/- mice exposed to 5-HT demonstrated an increased uptake of PI (). Similarly, after 1 wk of exposure to IL-6, only Tie2-deficient mice demonstrated TUNEL staining within peripheral regions of the lung (6%), whereas no staining was seen in WT mice (P < 0.01; Fig. 6 B).
###end p 19
###begin p 20
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of 5-HT or IL-6 on lung apoptosis.</bold>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 292 295 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 288 295 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 379 382 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 375 382 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
Effect of 5-HT or IL-6 on lung apoptosis. (A and B) Increased TUNEL staining in Tie2+/- compared with WT mice after exposure to 5-HT (A; n = 4 mice per group) or IL-6 (B; n = 4 mice per group) for 1 wk. TUNEL staining on 5-microm-thick paraffin-embedded lung sections from (a) WT and (c) Tie2+/- mice. Merged image of TUNEL and nuclear stainings (TO-PRO-3) of (b) WT and (d) Tie2+/- mice (arrows indicate TUNEL-positive cells). (e) Magnified view of TUNEL-positive cells (arrows) and (f) the percentage of TUNEL-positive cells. Results in A and B are from two independent experiments. Data are presented as means +/- SEM. **, P < 0.01 versus WT. Bars: (a-d) 50 microm; (d, inset) 25 microm; (e) 12.5 microm.
###end p 20
###begin title 21
Effect of reduced Tie2 expression and 5-HT on pulmonary artery EC survival
###end title 21
###begin p 22
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 369 377 357 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 393 397 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 578 586 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 142 147 <span type="species:ncbi:9606">human</span>
###xml 504 510 <span type="species:ncbi:9913">bovine</span>
To further define the effect of decreased Tie2 receptor expression and signaling on EC survival in response to 5-HT, Tie2 was knocked down in human pulmonary artery ECs using specific silencing siRNA. Transfection with specific siRNA reduced Tie2 protein expression by approximately50% by Western analysis, compared with control, scrambled siRNA-treated ECs (P < 0.01; Fig. 7 A). Furthermore, Tie2 silencing significantly enhanced EC apoptosis induced by 10 microM 5-HT cultured in low serum (0.2% fetal bovine serum) compared with cells treated with scrambled siRNA (P < 0.01; Fig. 7 B).
###end p 22
###begin p 23
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of 5-HT on pulmonary artery ECs deficient in Tie2 expression.</bold>
###xml 150 154 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 427 428 423 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 307 312 <span type="species:ncbi:9606">human</span>
Effect of 5-HT on pulmonary artery ECs deficient in Tie2 expression. (A) Decreased Tie2 protein expression in human pulmonary artery ECs subjected to Tie2-specific silencing siRNA compared with control (scrambled siRNA; n = 4 per group). (B) Percentage of cell death by annexin V/PI-based flow cytometry in human pulmonary artery ECs treated with control (scrambled) or Tie2 siRNA, and stimulated with 10 microM 5-HT for 24 h (n = 4 per group). Results in A and B are from four independent experiments. Data are presented as means +/- SEM. *, P < 0.05; **, P < 0.01 as indicated.
###end p 23
###begin title 24
Effect of 5-HT or IL-6 on pulmonary vascular remodeling
###end title 24
###begin p 25
###xml 143 147 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 192 196 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 196 199 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 313 317 309 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 317 320 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 378 393 374 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8, A and B</xref>
###xml 512 516 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 516 519 512 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 341 345 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
Exposure to 5-HT for 1 wk did not result in any differences in the muscularization of pulmonary vessels <50 microm in diameter in either WT or Tie2-deficient mice (unpublished data). However, Tie2+/- mice exposed to 2 wk of IL-6 demonstrated a significant increase in muscularization compared with saline-treated Tie2+/- and IL-6-treated WT mice (P < 0.01 for both comparisons; Fig. 8, A and B). Preliminary studies demonstrated no overt phenotypic differences in extracellular matrix composition between WT and Tie2+/- mice after exposure to 5-HT or IL-6 ().
###end p 25
###begin p 26
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of IL-6 on pulmonary arterial medial thickening.</bold>
###xml 194 197 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 190 197 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 245 248 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 241 248 237 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 255 256 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 382 385 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 378 385 370 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 475 478 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 471 478 463 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 485 486 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 491 495 <span type="species:ncbi:10090">mice</span>
Effect of IL-6 on pulmonary arterial medial thickening. (A) Immunofluorescent images of vessels stained with alpha-smooth muscle actin from 2 wk of (a) saline-treated WT, (b) saline-treated Tie2+/-, (c) IL-6-treated WT, and (d) IL-6-treated Tie2+/- mice (n = 4 mice per group). (B) Increased percentage of wall thickness of pulmonary arteries <50 microm in external diameter in Tie2+/- mice exposed to IL-6 for 2 wk compared with WT mice and compared with saline-treated Tie2+/- mice (n = 4 mice per group). Results are from two independent experiments. Data are presented as means +/- SEM. **, P < 0.01 as indicated. Bars, 25 microm.
###end p 26
###begin title 27
###xml 20 35 <span type="species:ncbi:10090">transgenic mice</span>
Lack of PAH in Ang1 transgenic mice
###end title 27
###begin p 28
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 504 512 504 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Fig. 9 A</xref>
###xml 568 572 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 828 836 828 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig9">Fig. 9 B</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
Protein expression of the human Ang1 transgene was detected in the mouse plasma of binary transgenic (BT) mice after induction by doxycycline withdrawal (). To define the effects of Ang1 overexpression on the development of PAH, RVSP and RV hypertrophy were determined in 11-12-wk-old Ang1 BT mice and non-BT (NBT) littermate controls that had been released from doxycycline suppression at 3 wk of age, and then received infusions of 5-HT or saline for 1 wk before end-study assessments. As presented in Fig. 9 A, there were no significant differences in RVSP between Ang1 BT and NBT mice receiving either saline or 5-HT infusions; if anything, RVSP tended to be reduced in BT mice, but this was not significant. As well, no differences in RV hypertrophy were observed between the groups after 1 wk of saline or 5-HT treatment (Fig. 9 B).
###end p 28
###begin p 29
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of Ang1 overexpression on RVSP and RV hypertrophy.</bold>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 137 138 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">Mice</span>
Effect of Ang1 overexpression on RVSP and RV hypertrophy. (A and B) No effect on RVSP (A; n = 6-10 mice per group) or RV hypertrophy (B; n = 6-10 mice per group) in NBT and Ang1 BT mice treated with 5 nmol/h 5-HT for 1 wk. Mice were released from doxycycline suppression at 3 wk of age and exposed to 5-HT for 1 wk at 11-12 wk of age. Results are from three independent experiments. Data are presented as means +/- SEM.
###end p 29
###begin title 30
Effect of caspase inhibition
###end title 30
###begin p 31
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 239 242 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 345 354 345 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig10">Fig. 10 A</xref>
###xml 431 440 431 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig10">Fig. 10 B</xref>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 514 517 514 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
To further establish the role of EC apoptosis in the exaggerated pulmonary hypertensive response to 5-HT in vivo, we treated WT or Tie2-deficient animals with a pan-caspase inhibitor, Z-VAD. In WT mice, Z-VAD had no effect, whereas in Tie2+/- mice, this treatment completely prevented the exaggerated increase in RVSP induced by 5-HT (P < 0.01; Fig. 10 A). In addition, no significant change in RV hypertrophy was present at 1 wk (Fig. 10 B). Furthermore, no TUNEL-positive cells were detected in the lungs of Tie2+/- mice receiving both 5-HT and Z-VAD (not depicted).
###end p 31
###begin p 32
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Effect of Z-VAD on 5-HT&#8211;treated WT and <italic>Tie2<sup>+/&#8722;</sup></italic> mice.</bold>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 400 403 398 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 396 403 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2<sup>+/&#8722;</sup></italic>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
Effect of Z-VAD on 5-HT-treated WT and Tie2+/- mice. (A) Significant decrease in RVSP in 5-HT-treated Tie2+/- mice after simultaneous treatment with 3 mg/kg Z-VAD for 1 wk (n = 3-5 mice per group). (B) No significant change in RV hypertrophy was observed (n = 3-5 mice per group). Results are from two independent experiments. Data are presented as means +/- SEM. **, P < 0.01 versus 5-HT + DMSO Tie2+/- mice.
###end p 32
###begin title 33
DISCUSSION
###end title 33
###begin p 34
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 374 378 374 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 649 653 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 782 785 782 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
In this study, we examined whether alterations in Tie2 activity would protect or predispose to the development of PAH using loss- and gain-of-function transgenic models. Ang1 overexpression by itself did not induce PAH, and Tie2 haploinsufficiency resulted in spontaneous increases in RVSP in a small proportion of mice under basal conditions. Moreover chronic treatment of Tie2-deficient mice with 5-HT or IL-6 unmasked significant elevation in pulmonary arterial pressures compared with WT animals. These interventions also reduced lung Ang1 levels and Tie2 activity, and induced EC apoptosis both in vivo and in vitro, but only in the context of Tie2 deficiency. As well, inhibition of apoptosis with Z-VAD completely prevented the pulmonary hypertensive response to 5-HT in Tie2+/- mice. These data strongly suggest that the Ang1-Tie2 pathway protects against PAH, in large part by promoting EC survival under conditions of serotonergic or inflammatory stress, both of which have been strongly implicated in the pathogenesis of this disease.
###end p 34
###begin p 35
###xml 562 596 562 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">Taraseviciene-Stewart et al., 2001</xref>
###xml 663 684 663 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Janssens et al., 1996</xref>
###xml 686 707 686 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Campbell et al., 2001</xref>
###xml 709 726 709 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib68">Zhao et al., 2003</xref>
###xml 728 751 728 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Kugathasan et al., 2005</xref>
###xml 753 770 753 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib69">Zhao et al., 2005</xref>
The distal pulmonary arteriolar bed is unique in that it consists of little more than an endothelial tube with scant matrix and few, if any, supporting mural cells. Thus, the ECs of the precapillary arterioles may be particularly vulnerable to injurious stimuli, and thereby more dependent on survival signaling, such as that afforded by Ang1 and vascular endothelial growth factor, to maintain lung vascular homeostasis. This is consistent with previous observations that inhibiting vascular endothelial growth factor signaling can potentiate experimental PAH (Taraseviciene-Stewart et al., 2001), whereas overexpression of angiogenic factors can be protective (Janssens et al., 1996; Campbell et al., 2001; Zhao et al., 2003; Kugathasan et al., 2005; Zhao et al., 2005). Moreover, we hypothesize that the functional consequences of even low levels of EC apoptosis may be particularly important for this region, because there is a finite possibility that this could disrupt the functional continuity between the arteriolar and capillary circulations, effectively excluding an "arteriolar-capillary unit" from the efficient "low pressure" pulmonary circulation. If this occurs repeatedly over time throughout the lung microvasculature, this would result in progressive increases in pulmonary vascular resistance.
###end p 35
###begin p 36
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 321 339 321 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Davis et al., 1996</xref>
###xml 502 527 502 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">Maisonpierre et al., 1997</xref>
###xml 639 656 639 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Wong et al., 1997</xref>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 930 934 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 687 691 <span type="species:ncbi:10090">mice</span>
Tie2 is an endothelial-selective receptor tyrosine kinase that is essential for vascular growth and remodeling. A null mutation of Tie2 results in embryonic lethality at E9.5-12.5 with marked vascular abnormalities, including reduced vascular complexity, increased EC apoptosis, and an absence in mural cell recruitment (Davis et al., 1996). Furthermore, Ang1 is highly expressed by SMCs and pericytes in the postnatal vasculature, and promotes vascular stabilization and maintenance of EC quiescence (Maisonpierre et al., 1997). Of interest, the lung exhibits some of the highest levels of basal Ang1 expression of any organ in the body (Wong et al., 1997). In addition, Tie2-deficient mice exhibited a marked down-regulation of lung eNOS protein levels, and any reduction in the release of the vascular protective and EC survival factor, NO, could contribute to EC dysfunction and loss in this model. Thus, we hypothesized that Tie2 deficiency would exaggerate pulmonary vascular response to relevant environmental triggers of PAH by predisposing to EC apoptosis and microvascular degeneration.
###end p 36
###begin p 37
###xml 200 227 200 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Thistlethwaite et al., 2001</xref>
###xml 229 244 229 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Du et al., 2003</xref>
###xml 532 559 532 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Thistlethwaite et al., 2001</xref>
###xml 561 576 561 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Du et al., 2003</xref>
###xml 710 727 710 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">Wong et al., 1997</xref>
###xml 729 755 729 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">Witzenbichler et al., 1998</xref>
###xml 757 780 757 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Abdulmalek et al., 2001</xref>
###xml 782 805 782 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Kugathasan et al., 2005</xref>
###xml 884 907 884 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Kugathasan et al., 2005</xref>
###xml 909 931 909 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Dewachter et al., 2006</xref>
###xml 1078 1105 1078 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">Thistlethwaite et al., 2001</xref>
###xml 350 358 <span type="species:ncbi:9606">patients</span>
###xml 512 517 <span type="species:ncbi:9606">human</span>
###xml 686 691 <span type="species:ncbi:9606">human</span>
Despite the evidence supporting a key role for the Ang1-Tie2 pathway in maintaining vascular homeostasis, it has previously been suggested that Ang1 may be causally related to the development of PAH (Thistlethwaite et al., 2001; Du et al., 2003). This was based on the observation that Ang1 was robustly expressed in lung samples from associated PAH patients, and was strongly correlated with increases in pulmonary vascular resistance, whereas Ang1 protein and Tie2 activity were nearly undetectable in control human lung samples (Thistlethwaite et al., 2001; Du et al., 2003). However, these findings are in conflict with other reports showing that Ang1 is highly expressed in normal human and rodent lungs (Wong et al., 1997; Witzenbichler et al., 1998; Abdulmalek et al., 2001; Kugathasan et al., 2005), and an up-regulation of Ang1 in PAH has not been confirmed by other groups (Kugathasan et al., 2005; Dewachter et al., 2006). It is possible that the near-complete absence of Ang1 mRNA and protein expression in control lung samples in the initial Thistlethwaite report (Thistlethwaite et al., 2001) was related to their use of lobectomy samples from routine surgeries, which are often subjected to variability in processing speed and duration to storage before analysis. Indeed, we have found that the levels of Ang1 mRNA and protein fall off precipitously even after a 15-min delay in the processing of lung samples (unpublished data).
###end p 37
###begin p 38
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 182 203 182 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Sullivan et al., 2003</xref>
###xml 205 221 205 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib78">Chu et al., 2004</xref>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 354 371 354 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Kido et al., 2005</xref>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 601 621 601 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">Vikkula et al., 1996</xref>
###xml 665 669 665 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 934 938 934 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 1144 1148 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 1231 1248 1231 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib68">Zhao et al., 2003</xref>
###xml 1250 1273 1250 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Kugathasan et al., 2005</xref>
###xml 383 391 <span type="species:ncbi:9606">patients</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 1180 1184 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
The Thistlethwaite group also demonstrated that increasing Tie2 activity by Ang1 gene transfer resulted in medial hyperplasia of pulmonary arterioles, vascular obstruction, and PAH (Sullivan et al., 2003; Chu et al., 2004), whereas inhibition of this signaling pathway via gene transfer of the extracellular domain of Tie2 (soluble Tie2) was protective (Kido et al., 2005). However, patients with an activating mutation of Tie2 show no evidence of PAH but rather develop large venous malformations, which exhibit either normal muscularization or vascular walls that are totally devoid of medial SMCs (Vikkula et al., 1996). Moreover, using a conditional transgenic Ang1 overexpression strategy to avoid the confounding effects of viral vectors, we found no evidence of an increase in RVSP or RV remodeling even 9 wk after induction of Ang1 gene expression. Furthermore, BT mice harboring both the tetracycline trans-activator and the Ang1 transgenes showed no evidence of enhanced susceptibility to PAH in response to serotonergic stress, and if anything, this was blunted. These findings are consistent with previous studies in which nonviral Ang1 gene transfer prevented PAH in rats in both the monocrotaline and hypoxia models (Zhao et al., 2003; Kugathasan et al., 2005).
###end p 38
###begin p 39
###xml 799 820 799 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">Sullivan et al., 2003</xref>
###xml 822 839 822 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Kido et al., 2005</xref>
###xml 1033 1053 1033 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">Robbins et al., 1998</xref>
###xml 1055 1074 1055 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">Tsao and Chen, 2002</xref>
###xml 1076 1093 1076 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib66">Yang et al., 2007</xref>
The reasons for the marked discrepancies between our findings and those of the Thistlethwaite group are not clear; however, this may relate to differences in the experimental approaches. For example, their studies used viral vectors for gene transfer that can induce inflammation. It is also possible that differences in the overall magnitude of transgene expression (i.e., "dose") or spatial distribution may have contributed to these divergent results, and that higher levels of local Ang1 expression within the lung microvasculature could induce nonphysiological effects, such as increased muscularization and arterial remodeling. Finally, surgical manipulation such as the clamping of the pulmonary veins that was used to enhance the levels of transgene expression in the lung in these studies (Sullivan et al., 2003; Kido et al., 2005) could have damaged these delicate venous structures. It is well established in the electrophysiology literature that injury to pulmonary veins is an important cause of pulmonary hypertension (Robbins et al., 1998; Tsao and Chen, 2002; Yang et al., 2007). In our study, the use of a conditional, targeted transgenic model may have avoided some of these confounding effects.
###end p 39
###begin p 40
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 589 594 589 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMPR2</italic>
###xml 619 636 619 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">West et al., 2008</xref>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1318 1337 1318 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">Newman et al., 2004</xref>
###xml 1339 1356 1339 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Song et al., 2005</xref>
###xml 1358 1375 1358 1375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Long et al., 2006</xref>
###xml 1377 1394 1377 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">Song et al., 2008</xref>
###xml 1470 1487 1470 1487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Long et al., 2006</xref>
###xml 1516 1533 1516 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">Song et al., 2005</xref>
###xml 1596 1601 1596 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMPR2</italic>
###xml 1601 1604 1601 1604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1632 1636 1632 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 1714 1719 1714 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMPR2</italic>
###xml 1719 1722 1719 1722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1746 1763 1746 1763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Long et al., 2006</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 606 611 <span type="species:ncbi:10090">mouse</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 1605 1609 <span type="species:ncbi:10090">mice</span>
###xml 1647 1651 <span type="species:ncbi:10090">mice</span>
###xml 1740 1744 <span type="species:ncbi:10090">mice</span>
Of note, we found an increase in basal levels of Ang1 in Tie2+/- compared with WT mice, which was associated with decreased Ang2 expression. This resulted in a marked increase in the ratio of the Tie2 agonist over the antagonist, which could serve to enhance activation of the remaining receptors, possibly in compensation for the effects of Tie2 haploinsufficiency. Although overt PAH was not evident in most Tie2-deficient mice, abnormalities in distal microcirculatory perfusion were revealed by fluorescent microangiography, which were similar to those observed in a dominant-negative BMPR2 transgenic mouse model (West et al., 2008) and consistent with subthreshold effects on vascular structure and function. In the present study, exposure to 5-HT or IL-6 alone did not induce a significant elevation in RVSP in WT mice; similarly, Tie2 deficiency by itself resulted in only a minor effect. However, the combination of these genetic and environmental influences appeared to have "synergistic" effects resulting in the initiation of pulmonary apoptosis and the development of significant PAH. This is consistent with the "second-hit" hypothesis for the pathogenesis of this disease, in which the response to an environmental or endogenous trigger is enhanced by the presence of a sensitizing genetic abnormality (Newman et al., 2004; Song et al., 2005; Long et al., 2006; Song et al., 2008). In a manner analogous to the present findings, exposure to serotonergic (Long et al., 2006) or inflammatory stressors (Song et al., 2005) also produced an enhanced pulmonary hypertensive response in BMPR2+/- mice. Interestingly, as in Tie2-deficient mice, exposure to chronic hypoxia did not result in greater PAH in BMPR2+/- compared with WT mice (Long et al., 2006).
###end p 40
###begin p 41
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 306 309 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 667 671 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
Lung Ang1 protein levels were reduced by treatment with serotonergic or inflammatory mediators in both WT and Tie2+/- mice. This was associated with decreased Tie2 activation that was more pronounced in Tie2+/- compared with WT mice. Moreover, evidence of apoptosis was seen in the peripheral lungs in Tie2+/- mice exposed to 5-HT or IL-6 but not in WT littermates. Because Ang1 is primarily produced by periendothelial support cells, we examined the effect of these agents on Ang1 secretion by cultured pulmonary artery SMCs. In parallel to our findings in vivo, we observed a dose-dependent reduction in Ang1 secretion in response to both 5-HT and IL-6. Thus, in a Tie2-deficient genetic background, these mediators could act to interfere with an important compensatory mechanism and exacerbate the effect of haploinsufficiency on the activity of the Tie2 pathway.
###end p 41
###begin p 42
###xml 156 174 156 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Herv&#233; et al., 1995</xref>
###xml 176 196 176 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Humbert et al., 1995</xref>
###xml 198 215 198 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Itoh et al., 2006</xref>
###xml 275 296 275 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Eddahibi et al., 1997</xref>
###xml 298 321 298 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Golembeski et al., 2005</xref>
###xml 323 343 323 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib120">Steiner et al., 2009</xref>
###xml 451 472 451 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Chirinos et al., 2005</xref>
###xml 597 616 597 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib67">Yoshio et al., 1997</xref>
###xml 618 638 618 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">Lesprit et al., 1998</xref>
###xml 640 662 640 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">Nishimaki et al., 1999</xref>
###xml 745 750 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMPR2</italic>
###xml 840 858 840 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Hagen et al., 2007</xref>
###xml 1068 1086 1068 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Herv&#233; et al., 1995</xref>
###xml 1148 1168 1148 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Dempsie et al., 2008</xref>
###xml 1238 1258 1238 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">Rothman et al., 1999</xref>
###xml 1486 1506 1486 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">MacLean et al., 1996</xref>
###xml 1508 1530 1508 1530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">Morecroft et al., 1999</xref>
###xml 1532 1553 1532 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Eddahibi et al., 2000</xref>
###xml 1555 1574 1555 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Keegan et al., 2001</xref>
###xml 1576 1597 1576 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Hironaka et al., 2003</xref>
###xml 1599 1618 1599 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">Marcos et al., 2003</xref>
###xml 1620 1640 1620 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">MacLean et al., 2004</xref>
###xml 1642 1665 1642 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Guignabert et al., 2005</xref>
###xml 1667 1684 1667 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">Long et al., 2006</xref>
###xml 1686 1708 1686 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">Morecroft et al., 2007</xref>
###xml 1879 1896 1879 1896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">Lee et al. (1994)</xref>
###xml 2213 2217 2213 2217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
###xml 260 264 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 269 273 <span type="species:ncbi:10090">mice</span>
###xml 1008 1016 <span type="species:ncbi:9606">patients</span>
###xml 1293 1297 <span type="species:ncbi:10090">mice</span>
###xml 1958 1964 <span type="species:ncbi:9913">bovine</span>
5-HT and IL-6 may also exert direct effects on EC inflammation and survival. Both IL-6 and 5-HT are known to be elevated in the serum of patients with PAH (Herve et al., 1995; Humbert et al., 1995; Itoh et al., 2006), and they have been shown to induce PAH in rats and mice (Eddahibi et al., 1997; Golembeski et al., 2005; Steiner et al., 2009). Increased circulating IL-6 has also been shown to be associated with increased evidence of EC apoptosis (Chirinos et al., 2005). As well, this mediator has been strongly implicated in EC activation and proinflammatory signaling in the context of PAH (Yoshio et al., 1997; Lesprit et al., 1998; Nishimaki et al., 1999). Recently, it has been suggested that increased susceptibility to PAH induced by BMPR2 mutations may be attributable in part to the loss of inhibitory effects of BMPs on IL-6 (Hagen et al., 2007), resulting in a positive feedback loop of inflammatory cytokine signaling. Similarly, 5-HT has been strongly implicated in PAH, with idiopathic PAH patients demonstrating elevated circulating levels of 5-HT (Herve et al., 1995). In experimental models, administration of dexfenfluramine (Dempsie et al., 2008), a 5-HTT substrate that also elevates extracellular levels of 5-HT (Rothman et al., 1999), has been shown to induce PAH in mice. In addition, several genetic and pharmacological models to either increase or decrease the activity of 5-HT receptors or the transporter have further highlighted the role of 5-HT in PAH (MacLean et al., 1996; Morecroft et al., 1999; Eddahibi et al., 2000; Keegan et al., 2001; Hironaka et al., 2003; Marcos et al., 2003; MacLean et al., 2004; Guignabert et al., 2005; Long et al., 2006; Morecroft et al., 2007), in part through its direct stimulatory effects on pulmonary arterial SMCs. However, the effects of 5-HT on EC growth and survival have not been as extensively studied. Lee et al. (1994) have reported that although 5-HT stimulated DNA synthesis in bovine pulmonary artery SMCs, this effect was not seen in pulmonary artery ECs. Similarly, we found no effects of 5-HT on EC growth and survival under basal conditions, but substantial EC apoptosis was demonstrated in response to 5-HT after siRNA-induced Tie2 gene silencing. Thus, 5-HT may have differential effects on pulmonary vascular cells; although in SMCs it promotes proliferation, in ECs it may induce injury and apoptosis.
###end p 42
###begin p 43
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMPR2</italic>
###xml 154 187 154 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">Teichert-Kuliszewska et al., 2006</xref>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
This is analogous to the effects of BMPR2 deficiency or gene silencing, which also results in dysregulated SMC growth but unmasks increased EC apoptosis (Teichert-Kuliszewska et al., 2006). Moreover, we were able to establish that apoptosis was an important mechanism in the exaggerated PAH seen in Tie2-deficient animals in response to serotonergic stress, because this could be abrogated with the pan-caspase inhibitor Z-VAD. This is consistent with EC apoptosis playing a central role in the pathogenesis of PAH, possibly by leading directly to the degeneration and loss of function of distal precapillary arterioles. More importantly, these findings also emphasize the protective role of the Tie2 signaling pathway in preventing apoptosis and protecting against the development of PAH. Thus, interventions that inhibit the apoptotic cascade may be therapeutically useful in preventing the progression of PAH and need to be investigated.
###end p 43
###begin p 44
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 90 105 <span type="species:ncbi:10090">transgenic mice</span>
In this study, we have shown that Tie2 haploinsufficiency increased the susceptibility of transgenic mice to PAH, likely by sensitizing ECs to apoptosis in response to a second hit, such as exposure to 5-HT or a proinflammatory mediator. Both agents decreased Ang1 secretion, which in the Tie2-deficient background likely resulted in reduction in Tie2 activity below a critical threshold. In contrast to some previous reports, overexpression of Ang1 had no deleterious effects on pulmonary hemodynamics or vascular remodeling, a finding consistent with the now well-established role of Tie2 activity in maintaining vascular homeostasis. Collectively, these findings suggest that rather than promoting vascular remodeling and PAH, pulmonary Ang1 may be protective by supporting the basal activation of endothelial Tie2. Thus, these data may have important clinical implications by suggesting that therapeutic strategies based on inhibiting Tie2 activity may be harmful, whereas Ang1 and other Tie2 agonists may be useful in the treatment of this serious disorder.
###end p 44
###begin title 45
MATERIALS AND METHODS
###end title 45
###begin title 46
Animals
###end title 46
###begin p 47
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 344 348 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 421 425 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 349 364 <span type="species:ncbi:10090">transgenic mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 623 627 <span type="species:ncbi:10090">mice</span>
###xml 709 713 <span type="species:ncbi:10090">mice</span>
All animal procedures were approved by the Animal Care Committee of St. Michael's Hospital. Breeding pairs to generate Tie2+/- mice and Ang1 BT mice were provided by D.J. Dumont (University of Toronto, Toronto, Canada). WT littermates were used as controls in all experiments. Tie2+/- mice were generated by crossing Tie2+/- mice with WT mice. Ang1 transgenic mice were generated by breeding Enh-Tie2 tTA driver and pTET-Ang1 responder mice. Ang1 overexpression was suppressed throughout breeding by administering mice with drinking water containing 100 microg/ml doxycycline (Sigma-Aldrich). After weaning at 3 wk of age, mice were released from doxycycline, allowing for Ang1 overexpression. NBT littermate mice were used as controls. Offspring genotypes were determined via PCR (see Genotyping).
###end p 47
###begin title 48
Genotyping
###end title 48
###begin p 49
###xml 312 316 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 351 355 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 900 904 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 1013 1016 955 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 1053 1057 983 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 1069 1074 999 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hAng1</italic>
###xml 1098 1101 1016 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 1139 1142 1057 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tTA</italic>
###xml 1180 1185 1098 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hAng1</italic>
###xml 1228 1233 1146 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hAng1</italic>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 908 912 <span type="species:ncbi:10090">mice</span>
###xml 1047 1052 <span type="species:ncbi:9606">human</span>
Genomic DNA was extracted from mouse ear-notch samples, and PCR was performed using the buffers and PCR reaction mix from the REDExtract-N-Amp tissue PCR kit (Sigma-Aldrich), according to the manufacturer's instructions. A 0.5-microm mixture of the following primers was used in the PCR to detect the endogenous Tie2 (approximately150 bp) and mutated Tie2 (approximately450 bp): endogenous forward, 5'-AGCGCGTGGACCATGCGAGC-3'; endogenous reverse, 5'-CCATTGCTCAGCGGTGCTGTCCAT-3'; and mutant forward, 5'-AGGAGCAAGCTGACTCCACAG-3'. The PCR thermal cycling parameters included an initial denaturation at 94degreesC for 3 min, followed by 30 cycles consisting of denaturation at 95degreesC for 30 s, annealing at 54degreesC for 40 s, and extension at 72degreesC for 30 s According to this, a final extension at 72degreesC for 10 min was performed, and the amplified DNA was resolved in a 1.5% agarose gel. Ang1 BT mice were identified via PCR using the following primer pairs to detect the tetracycline transactivator (tTA; approximately500 bp) and the human Ang1 transgene (hAng1; approximately350 bp): tTA forward, 5'-CTCACTTTTGCCCTTTAGAA-3'; tTA reverse, 5'-GCTGTACGCGGACCCACTTT-3'; hAng1 forward, 5'-ATAGGAACCAGCCTCCTCTCT-3'; and hAng1 reverse 5'-AAGGACACTGTTGTTGGTGGTA-3'.
###end p 49
###begin title 50
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Detecting plasma human Ang1 in Ang1 BT mice
###end title 50
###begin p 51
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 156 161 <span type="species:ncbi:9606">Human</span>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
Cardiac puncture was performed on anesthetized mice, and blood was collected from both NBT and Ang1 BT mice. Plasma was isolated and stored at -80degreesC. Human Ang1 expression in mouse plasma was determined by ELISA according to the manufacturer's instructions (R&D Systems).
###end p 51
###begin title 52
In vivo experiments
###end title 52
###begin title 53
Hypoxia-induced PAH.
###end title 53
###begin p 54
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 243 244 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 303 304 303 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
Groups of three mice were placed in sealed Plexiglas, normobaric chambers (12 x 5 x 7 in) for 1 wk. The O2 concentration in the chamber was maintained at 8-10% by controlling the inflow rates from tanks containing mixed air and nitrogen. The O2 concentration in the chamber was measured daily using an O2 analyzer (Engineered Systems and Designs). Control mice were maintained in room air.
###end p 54
###begin title 55
5-HT-induced PAH.
###end title 55
###begin p 56
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
Tie2+/- and WT littermate mice as well as Ang1 BT and NBT littermate mice (11-12 wk old) received 5 nmol/h of 5-HT (Sigma-Aldrich) or saline (control) via s.c. placed osmotic mini pumps (Alzet Osmotic Pumps) over a 1-wk duration. In separate experiments, mice receiving either saline or 5-HT also received daily i.p. injection of 3 mg/kg of the pan-caspase inhibitor Z-VAD-FMK (R&D Systems) or DMSO (control) for 1 wk.
###end p 56
###begin title 57
IL-6-induced PAH.
###end title 57
###begin p 58
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 23 26 23 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
WT littermates and Tie2+/- mice received s.c. injections of 200 ng/kg/d of recombinant mouse IL-6 (Sigma-Aldrich) or saline (control) over a 1- or 2-wk duration.
###end p 58
###begin title 59
Hemodynamic evaluation
###end title 59
###begin p 60
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
Systemic SBP was determined by inserting a 1.4F Millar catheter (Millar Instruments, Inc.) into the left ventricle of anesthetized mice (200 mg/kg ketamine:10 mg/kg xylazine i.p.). Similarly, RVSP was determined in anesthetized mice by inserting the 1.4F Millar catheter into the RV. RV hypertrophy was assessed by evaluating the mass ratio of the RV to the left ventricle plus septum.
###end p 60
###begin title 61
Fluorescent microangiography
###end title 61
###begin p 62
###xml 32 51 32 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Dutly et al. (2006)</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
This technique was adapted from Dutly et al. (2006). In brief, mice were anaesthetized and the pulmonary vessels were flushed through the RV with a flushing buffer (10 mM sodium phosphate, 127 mM sodium chloride, 10 mM EDTA, 5 U/ml heparin). A 10% mixture of 0.2 microm of fluorescent yellow-green microbeads (FluoSpheres; Invitrogen) reconstituted in low-temperature melting point agarose was injected into the pulmonary circulation via the RV. Crushed ice was then placed atop the mice to enhance gelling of the microbead-agarose mixture. After this, the lungs were inflated with cold 4% paraformaldehyde (PFA), and the heart-lung block was fixed in 4% PFA for 48 h and transferred to PBS for storage. The whole top right lobe was subjected to fluorescent microscopy (1x magnification; Discovery V8 stereo microscope equipped with an AxioCam MR3 camera) and images were acquired using AxioVision LE 4.6 software (all from Carl Zeiss, Inc.).
###end p 62
###begin title 63
In vivo apoptosis analysis
###end title 63
###begin p 64
###xml 29 46 29 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Cho et al. (1995)</xref>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
This method was adapted from Cho et al. (1995). 5 micromol/kg PI (Sigma-Aldrich) was injected via the right external jugular vein of anesthetized mice (200 mg/kg ketamine:10 mg/kg xylazine) and allowed to circulate for 15 min before the mice were euthanized. The left atrium was transected, and the systemic and pulmonary circulations were flushed with PBS. Lungs were fixed in optimum cutting temperature and stored at -80degreesC overnight. The next day, 60-microm-thick cross sections of the left lobe of the lungs were cryosectioned for confocal microscopy. Cells that did not exclude the PI were considered to be nonviable.
###end p 64
###begin title 65
TUNEL
###end title 65
###begin p 66
###xml 541 545 <span type="species:ncbi:10090">mice</span>
Apoptotic cells were detected in 5-microm-thick paraffin-embedded sections using a fluorescent TUNEL assay kit (Promega) according to manufacturer's instructions. Nuclear counterstaining was performed using TO-PRO-3 (1:2,500; Invitrogen), and sections were examined by confocal microscopy (40x magnification; Radiance 2100) and images were acquired using LaserSharp software (both from Bio-Rad Laboratories). The number of TUNEL-positive nuclei was determined by examining four randomly selected microscopic fields from each of four to five mice from each experimental group. The percentage of TUNEL positivity was calculated as follows: (number of TUNEL-positive nuclei)/(total number of nuclei) x 100%.
###end p 66
###begin title 67
Western immunoblotting
###end title 67
###begin p 68
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 146 152 <span type="species:ncbi:9986">rabbit</span>
###xml 205 211 <span type="species:ncbi:9986">rabbit</span>
###xml 272 278 <span type="species:ncbi:9986">rabbit</span>
###xml 336 342 <span type="species:ncbi:9986">rabbit</span>
###xml 378 382 <span type="species:ncbi:9925">goat</span>
###xml 492 497 <span type="species:ncbi:10090">mouse</span>
Protein was extracted from the lungs of WT and Tie2+/- mice and subjected to immunoblotting. Membranes were incubated overnight at 4degreesC with rabbit eNOS antibody (1:1,000; Cell Signaling Technology), rabbit Phospho-Tie2 antibody (1:1,000; Cell Signaling Technology), rabbit Tie2 antibody (1:1,000; Santa Cruz Biotechnology, Inc.), rabbit Ang1 antibody (1:1,000; Abcam), or goat Ang2 antibody (1:500; Santa Cruz Biotechnology, Inc.), and equivalent protein loading was demonstrated using mouse beta-actin antibody (1:5,000; Sigma-Aldrich).
###end p 68
###begin title 69
Muscularization analysis
###end title 69
###begin p 70
###xml 410 429 402 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Beppu et al. (2004)</xref>
5-microm-thick paraffin-embedded sections were stained with a Cy3-conjugated monoclonal alpha-smooth muscle actin antibody (1:200; Sigma-Aldrich), and nuclei were counterstained using TO-PRO-3 (1:2,500). Sections were examined by confocal microscopy (80x magnification; Radiance 2100) and images were acquired using LaserSharp software. The percentage of wall thickness was determined using the methodology by Beppu et al. (2004) and was as follows: % wall thickness = (WT1 + WT2)/(external diameter of vessel) x 100%, where WT1 and WT2 refer to wall thicknesses measured at two points diametrically opposite to each other. For each vessel, the percentage of wall thickness was calculated as the average determined from four regions of measurement.
###end p 70
###begin title 71
Movat pentachrome staining
###end title 71
###begin p 72
###xml 312 316 <span type="species:ncbi:10090">mice</span>
The Movat pentachrome staining was performed on 5-microm-thick paraffin-embedded sections to demonstrate extracellular matrix components such as fibrin, collagen, elastin, and proteoglycans/glycosaminoglycans. Vessels from four to five randomly selected microscopic fields (10x magnification) from each of three mice from each experimental group were analyzed using a bright-field upright light microscope (model E800) equipped with a digital camera (DXM 1200), and images were acquired using Act-1 software (all from Nikon).
###end p 72
###begin title 73
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human pulmonary artery SMC culture
###end title 73
###begin p 74
###xml 180 182 180 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 185 187 185 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 279 284 <span type="species:ncbi:9606">human</span>
###xml 294 299 <span type="species:ncbi:9606">human</span>
Human pulmonary artery SMCs (Lonza, Ltd.) at 70-80% confluency were serum starved in basal medium with 0.1% BSA for 24 h and exposed to 5-HT (Sigma-Aldrich) at concentrations of 10-8-10-5 M for 24 h. In a separate experiment, serum-starved cells were exposed to a combination of human IL-6 and human sIL-6R (IL-6 + sIL-6R; Sigma-Aldrich), each at concentrations of 10, 50, and 100 ng/ml for 24 h. At the end of the experiments, supernatants were collected for ELISA and cells were harvested for protein quantification.
###end p 74
###begin title 75
Detecting membrane-bound IL-6R
###end title 75
###begin p 76
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 189 195 <span type="species:ncbi:9986">rabbit</span>
Protein was harvested from human pulmonary artery SMCs and human endothelial progenitor cells were cultured for 7 d (positive control). Membranes were incubated overnight at 4degreesC with rabbit IL-6R antibody (1:500; Santa Cruz Biotechnology, Inc.).
###end p 76
###begin title 77
ELISA
###end title 77
###begin p 78
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Human Ang1 levels from human pulmonary artery SMC supernatants were measured according to the manufacturer's instructions (R&D Systems).
###end p 78
###begin title 79
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human pulmonary artery EC Tie2 siRNA
###end title 79
###begin p 80
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 300 302 300 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 86 91 <span type="species:ncbi:9606">human</span>
siRNA-mediated inhibition of Tie2 gene expression (Santa Cruz Biotechnology, Inc.) in human pulmonary artery ECs (Lonza, Ltd.) was performed according to the manufacturer's instructions, and control cells were subjected to scrambled siRNA transfection. After siRNA treatment, cells were exposed to 10-5 M 5-HT in basal medium with 0.2% FBS for 24 h. At the end of this treatment, cells were labeled with annexin V and PI (Annexin-V-FLUOS staining kit; Roche) and analyzed by flow cytometry to determine the percentage of cell death.
###end p 80
###begin title 81
Statistical analysis
###end title 81
###begin p 82
###xml 125 126 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 185 186 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
All data are presented as means +/- SEM. For in vivo experiments, means of two groups were compared using either an unpaired t test, or when appropriate, the nonparametric Mann-Whitney U test. Differences among multiple means were determined by analysis of variance (ANOVA), followed by the Student-Newman-Keuls post-hoc analysis, or the nonparametric Kruskal-Wallis test followed by the Dunn's post-hoc analysis. For in vitro experiments, repeated-measures ANOVA was used when appropriate, followed by the Dunnett's post-hoc analysis.
###end p 82
###begin title 83
Online supplemental material
###end title 83
###begin p 84
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 301 304 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 411 415 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 415 418 415 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 506 510 506 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 510 513 510 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 659 663 659 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2</italic>
###xml 663 666 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 770 774 770 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang1</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 734 739 <span type="species:ncbi:9606">human</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
Fig. S1 demonstrates that hypoxia did not elicit more significant PAH in Tie2+/- compared with WT mice. Fig. S2 confirms that the membrane-bound IL-6R is not expressed in pulmonary arterial SMCs in culture. Fig. S3 demonstrates that lung eNOS protein levels are not significantly altered in WT or Tie2+/- mice after exposure to 5-HT, although a trend toward a decrease in eNOS protein levels was present in the Tie2+/- mice. Fig. S4 illustrates the presence of nonviable cells in the lungs of 5-HT-treated Tie2+/- mice via in vivo PI uptake. Fig. S5 demonstrates the absence of any overt phenotypic differences after Movat pentachrome staining between WT and Tie2+/- mice treated with 5-HT or IL-6. Fig. S6 confirms the expression of human Ang1 protein in the plasma of Ang1 BT mice. Online supplemental material is available at .
###end p 84
###begin title 85
Supplementary Material
###end title 85
###begin title 86
[Supplemental Material]
###end title 86
###begin p 87
We thank Ms. C. Wang, Mr. M. Robb, Dr. M. Golam Kabir, and Dr. R.N.N. Han for technical assistance, and Ms. L. Morikawa for the Movat pentachrome staining. We also thank Mr. P.F.H. Lai, Dr. M.E. Ward, and Dr. K. Teichert-Kuliszewska for helpful discussions.
###end p 87
###begin p 88
This work was supported by grants to D.J. Stewart from the Canadian Institutes of Health Research (MOP-57726 and MOP-82791), and L. Kugathasan holds a Doctoral Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.
###end p 88
###begin p 89
The authors have no conflicting financial interests.
###end p 89
###begin article-title 90
###xml 95 99 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats.
###end article-title 90
###begin article-title 91
Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle.
###end article-title 91
###begin article-title 92
###xml 21 25 <span type="species:ncbi:10090">mice</span>
BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia.
###end article-title 92
###begin article-title 93
Endothelial dysfunction in pulmonary hypertension.
###end article-title 93
###begin article-title 94
Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.
###end article-title 94
###begin article-title 95
###xml 176 180 <span type="species:ncbi:10090">mice</span>
Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice.
###end article-title 95
###begin article-title 96
###xml 115 118 <span type="species:ncbi:9606">men</span>
Correlation between apoptotic endothelial microparticles and serum interleukin-6 and C-reactive protein in healthy men.
###end article-title 96
###begin article-title 97
Apoptosis (programmed cell death) in arteries of the neonatal lamb.
###end article-title 97
###begin article-title 98
A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1.
###end article-title 98
###begin article-title 99
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.
###end article-title 99
###begin article-title 100
###xml 120 135 <span type="species:ncbi:10090">transgenic mice</span>
Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice.
###end article-title 100
###begin article-title 101
Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension.
###end article-title 101
###begin article-title 102
Signaling molecules in nonfamilial pulmonary hypertension.
###end article-title 102
###begin article-title 103
Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo.
###end article-title 103
###begin article-title 104
Fluorescent microangiography (FMA): an improved tool to visualize the pulmonary microvasculature.
###end article-title 104
###begin article-title 105
###xml 93 97 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats.
###end article-title 105
###begin article-title 106
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene.
###end article-title 106
###begin article-title 107
Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.
###end article-title 107
###begin article-title 108
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice.
###end article-title 108
###begin article-title 109
###xml 103 107 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats.
###end article-title 109
###begin article-title 110
Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle.
###end article-title 110
###begin article-title 111
Increased plasma serotonin in primary pulmonary hypertension.
###end article-title 111
###begin article-title 112
###xml 109 113 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats.
###end article-title 112
###begin article-title 113
Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.
###end article-title 113
###begin article-title 114
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension.
###end article-title 114
###begin article-title 115
###xml 36 41 <span type="species:ncbi:9606">human</span>
###xml 133 137 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats.
###end article-title 115
###begin article-title 116
###xml 134 138 <span type="species:ncbi:10090">mice</span>
Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.
###end article-title 116
###begin article-title 117
Gene transfer of a TIE2 receptor antagonist prevents pulmonary hypertension in rodents.
###end article-title 117
###begin article-title 118
Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway.
###end article-title 118
###begin article-title 119
###xml 43 48 <span type="species:ncbi:9606">human</span>
Role of angiopoietin-1 in experimental and human pulmonary arterial hypertension.
###end article-title 119
###begin article-title 120
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Angiopoietin-like protein 1 decreases blood brain barrier damage and edema following focal cerebral ischemia in mice.
###end article-title 120
###begin article-title 121
###xml 55 61 <span type="species:ncbi:9913">bovine</span>
Serotonin produces both hyperplasia and hypertrophy of bovine pulmonary artery smooth muscle cells in culture.
###end article-title 121
###begin article-title 122
Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor.
###end article-title 122
###begin article-title 123
Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines.
###end article-title 123
###begin article-title 124
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
###end article-title 124
###begin article-title 125
###xml 119 123 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.
###end article-title 125
###begin article-title 126
Overexpression of the 5-hydroxytryptamine transporter gene: effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension.
###end article-title 126
###begin article-title 127
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
###end article-title 127
###begin article-title 128
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
###end article-title 128
###begin article-title 129
Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha.
###end article-title 129
###begin article-title 130
###xml 55 60 <span type="species:ncbi:9606">human</span>
5-hydroxytryptamine receptors mediating contraction in human small muscular pulmonary arteries: importance of the 5-HT1B receptor.
###end article-title 130
###begin article-title 131
Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.
###end article-title 131
###begin article-title 132
Genetic basis of pulmonary arterial hypertension: current understanding and future directions.
###end article-title 132
###begin article-title 133
Immunological analysis of pulmonary hypertension in connective tissue diseases.
###end article-title 133
###begin article-title 134
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway.
###end article-title 134
###begin article-title 135
Pulmonary vein stenosis after catheter ablation of atrial fibrillation.
###end article-title 135
###begin article-title 136
Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension.
###end article-title 136
###begin article-title 137
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.
###end article-title 137
###begin article-title 138
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice.
###end article-title 138
###begin article-title 139
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.
###end article-title 139
###begin article-title 140
Interleukin-6 overexpression induces pulmonary hypertension.
###end article-title 140
###begin article-title 141
Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway.
###end article-title 141
###begin article-title 142
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.
###end article-title 142
###begin article-title 143
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
###end article-title 143
###begin article-title 144
Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.
###end article-title 144
###begin article-title 145
Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
###end article-title 145
###begin article-title 146
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy.
###end article-title 146
###begin article-title 147
Evaluation of pulmonary vein stenosis after catheter ablation of atrial fibrillation.
###end article-title 147
###begin article-title 148
The pathobiology of pulmonary hypertension. Endothelium.
###end article-title 148
###begin article-title 149
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.
###end article-title 149
###begin article-title 150
Pathology of pulmonary hypertension.
###end article-title 150
###begin article-title 151
The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development.
###end article-title 151
###begin article-title 152
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions.
###end article-title 152
###begin article-title 153
Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2.
###end article-title 153
###begin article-title 154
Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues.
###end article-title 154
###begin article-title 155
Irreversible intrapulmonary vascular changes after pulmonary vein stenosis complicating catheter ablation for atrial fibrillation.
###end article-title 155
###begin article-title 156
Association of interleukin 6 release from endothelial cells and pulmonary hypertension in SLE.
###end article-title 156
###begin article-title 157
Protective role of angiopoietin-1 in experimental pulmonary hypertension.
###end article-title 157
###begin article-title 158
Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
###end article-title 158
###begin p 159
###xml 0 19 0 19 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="160">Abbreviations used:</title>
###xml 19 23 19 23 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5-HT</term>
###xml 23 32 23 32 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="161">serotonin</p>
###xml 23 32 23 32 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="161">serotonin</p></def>
###xml 19 32 19 32 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>5-HT</term><def><p textid="161">serotonin</p></def></def-item>
###xml 32 35 32 35 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ang</term>
###xml 35 47 35 47 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="162">angiopoietin</p>
###xml 35 47 35 47 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="162">angiopoietin</p></def>
###xml 32 47 32 47 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>Ang</term><def><p textid="162">angiopoietin</p></def></def-item>
###xml 47 49 47 49 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BT</term>
###xml 49 66 49 66 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="163">binary transgenic</p>
###xml 49 66 49 66 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="163">binary transgenic</p></def>
###xml 47 66 47 66 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>BT</term><def><p textid="163">binary transgenic</p></def></def-item>
###xml 66 68 66 68 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EC</term>
###xml 68 84 68 84 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="164">endothelial cell</p>
###xml 68 84 68 84 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="164">endothelial cell</p></def>
###xml 66 84 66 84 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>EC</term><def><p textid="164">endothelial cell</p></def></def-item>
###xml 84 88 84 88 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eNOS</term>
###xml 88 111 88 111 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="165">endothelial NO synthase</p>
###xml 88 111 88 111 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="165">endothelial NO synthase</p></def>
###xml 84 111 84 111 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>eNOS</term><def><p textid="165">endothelial NO synthase</p></def></def-item>
###xml 111 114 111 114 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NBT</term>
###xml 114 120 114 120 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="166">non-BT</p>
###xml 114 120 114 120 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="166">non-BT</p></def>
###xml 111 120 111 120 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>NBT</term><def><p textid="166">non-BT</p></def></def-item>
###xml 120 123 120 123 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAH</term>
###xml 123 154 123 154 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="167">pulmonary arterial hypertension</p>
###xml 123 154 123 154 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="167">pulmonary arterial hypertension</p></def>
###xml 120 154 120 154 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PAH</term><def><p textid="167">pulmonary arterial hypertension</p></def></def-item>
###xml 154 156 154 156 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PI</term>
###xml 156 172 156 172 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="168">propidium iodide</p>
###xml 156 172 156 172 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="168">propidium iodide</p></def>
###xml 154 172 154 172 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>PI</term><def><p textid="168">propidium iodide</p></def></def-item>
###xml 172 174 172 174 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RV</term>
###xml 174 189 174 189 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="169">right ventricle</p>
###xml 174 189 174 189 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="169">right ventricle</p></def>
###xml 172 189 172 189 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>RV</term><def><p textid="169">right ventricle</p></def></def-item>
###xml 189 193 189 193 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RVSP</term>
###xml 193 228 193 228 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="170">right ventricular systolic pressure</p>
###xml 193 228 193 228 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="170">right ventricular systolic pressure</p></def>
###xml 189 228 189 228 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>RVSP</term><def><p textid="170">right ventricular systolic pressure</p></def></def-item>
###xml 228 231 228 231 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SBP</term>
###xml 231 254 231 254 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="171">systolic blood pressure</p>
###xml 231 254 231 254 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="171">systolic blood pressure</p></def>
###xml 228 254 228 254 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>SBP</term><def><p textid="171">systolic blood pressure</p></def></def-item>
###xml 254 260 254 260 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sIL-6R</term>
###xml 260 273 260 273 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="172">soluble IL-6R</p>
###xml 260 273 260 273 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="172">soluble IL-6R</p></def>
###xml 254 273 254 273 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>sIL-6R</term><def><p textid="172">soluble IL-6R</p></def></def-item>
###xml 273 276 273 276 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SMC</term>
###xml 276 294 276 294 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="173">smooth muscle cell</p>
###xml 276 294 276 294 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="173">smooth muscle cell</p></def>
###xml 273 294 273 294 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>SMC</term><def><p textid="173">smooth muscle cell</p></def></def-item>
###xml 294 299 294 299 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TUNEL</term>
###xml 299 368 299 368 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="174">terminal deoxynucleotidyl transferase&#8211;mediated dUTP nick-end labeling</p>
###xml 299 368 299 368 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="174">terminal deoxynucleotidyl transferase&#8211;mediated dUTP nick-end labeling</p></def>
###xml 294 368 294 368 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>TUNEL</term><def><p textid="174">terminal deoxynucleotidyl transferase&#8211;mediated dUTP nick-end labeling</p></def></def-item>
###xml 0 368 0 368 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="160">Abbreviations used:</title><def-item><term>5-HT</term><def><p textid="161">serotonin</p></def></def-item><def-item><term>Ang</term><def><p textid="162">angiopoietin</p></def></def-item><def-item><term>BT</term><def><p textid="163">binary transgenic</p></def></def-item><def-item><term>EC</term><def><p textid="164">endothelial cell</p></def></def-item><def-item><term>eNOS</term><def><p textid="165">endothelial NO synthase</p></def></def-item><def-item><term>NBT</term><def><p textid="166">non-BT</p></def></def-item><def-item><term>PAH</term><def><p textid="167">pulmonary arterial hypertension</p></def></def-item><def-item><term>PI</term><def><p textid="168">propidium iodide</p></def></def-item><def-item><term>RV</term><def><p textid="169">right ventricle</p></def></def-item><def-item><term>RVSP</term><def><p textid="170">right ventricular systolic pressure</p></def></def-item><def-item><term>SBP</term><def><p textid="171">systolic blood pressure</p></def></def-item><def-item><term>sIL-6R</term><def><p textid="172">soluble IL-6R</p></def></def-item><def-item><term>SMC</term><def><p textid="173">smooth muscle cell</p></def></def-item><def-item><term>TUNEL</term><def><p textid="174">terminal deoxynucleotidyl transferase&#8211;mediated dUTP nick-end labeling</p></def></def-item></def-list>
Abbreviations used:5-HTserotoninAngangiopoietinBTbinary transgenicECendothelial celleNOSendothelial NO synthaseNBTnon-BTPAHpulmonary arterial hypertensionPIpropidium iodideRVright ventricleRVSPright ventricular systolic pressureSBPsystolic blood pressuresIL-6Rsoluble IL-6RSMCsmooth muscle cellTUNELterminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling
###end p 159
###begin title 160
Abbreviations used:
###end title 160
###begin p 161
serotonin
###end p 161
###begin p 162
angiopoietin
###end p 162
###begin p 163
binary transgenic
###end p 163
###begin p 164
endothelial cell
###end p 164
###begin p 165
endothelial NO synthase
###end p 165
###begin p 166
non-BT
###end p 166
###begin p 167
pulmonary arterial hypertension
###end p 167
###begin p 168
propidium iodide
###end p 168
###begin p 169
right ventricle
###end p 169
###begin p 170
right ventricular systolic pressure
###end p 170
###begin p 171
systolic blood pressure
###end p 171
###begin p 172
soluble IL-6R
###end p 172
###begin p 173
smooth muscle cell
###end p 173
###begin p 174
terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling
###end p 174

